A Review Of The Eye Machine & Its Technology
The Eye Machine, LLC was formed in 2014 to develop and manufacture a medical device to treat macular degeneration. The goal is to lease these devices to optometrists and other medical professionals in order for them to help their patients with age-related macular degeneration.
The National Eye Institute notes that over 10 million people in the United States have a form of age-related macular degeneration. Also, they indicate that more than 1 in 10 people over the age of 70 have experienced some vision loss to the disease. With this many people suffering from loss of vision, The Eye Machine, LLC needed to step forward and take a stance to help the movement toward a solution. Our unique technology is at the forefront of ophthalmologic science.
Unfortunately, age-related macular degeneration is the number one cause of legal blindness in adults over the age of 50 years. As the “baby boomers” age, there will be an increase the number of people with AMD. By honing our new technology, we will meet a growing population of people with macular degeneration.
What Is AMD?
AMD is a breakdown of the macula in the retina. A “black cloud” forms in the patient’s central vision, making it difficult to perform everyday activities such as driving, reading, watching television, and working on a computer. This eye disease progressively deteriorates the patient’s vision. It can even impair their ability to see color and contrast in objects. The innovators of the technology behind The Eye Machine are dedicated to helping those who suffer with AMD regain some of their vision. By Improving the metabolism of the cells, it helps to generate healthier photoreceptors in the macula. This creates the potential for the improvement of the patient’s vision.
How Does It Work?
This effective, non-invasive treatment for AMD is revolutionary and is used for all forms of macular degeneration. The technology uses BioCurrent Therapy which emits targeted frequencies to stimulate a response at the retinal level. By doing this, the cells and blood vessels receive a better oxygen flow. This also allows more nutrition to be delivered to the cells.
The electrotherapy treatment delivers a low level of electric current to the eye. Each one-hour procedure, which incorporates a special type of goggle to deliver the current, has been shown by studies to improve movement of nutrition from the blood to the cells. These special goggles work with a generator station to deliver micro current in a patented waveform to four places on the closed eye lid. The four sites consist of the upper left lid, the lower left lid, upper right lid and lower right lid. Each area takes 40 seconds to deliver the electric current effectively.
While the technology still needs to complete a regulatory approval process with the FDA, it is expected to be the future of treating patients with AMD
Their Mission & Focus
Our team here at The Eye Machine, LLC brings a variety of disciplines to the company. Michael Samuel M.D., our Medical Advisor. He is nationally known for research, clinical work, and surgery. He was a part of a team that performed the first surgical implant of stem cells for dry macular degeneration. We are fortunate to have him as our medical advisor for The Eye Machine. Dr. George O’Clock, Ph.D. is our Chief Science Advisor. His extensive experience in technologies that successfully treats eye disease makes him the ideal advisor for this mission.
While the technology still needs to complete a regulatory approval process with the FDA, it is expected to be the future of treating patients with AMD.
Read more about their exciting new technology on our website or contact us for more information. please call us at (760) 292-2805 or visit our website. They are located at 74-900 Highway 111, Suite 127, Indian Wells, California 92210.